crc-research

Skip to content The CRC Digest 30-year analysis reveals evolving patterns in early-onset CRC Researchers tracked changes in how colorectal cancer presents in patients under 50 across three decades in Scandinavia. (Journal of Surgical Oncology) This content is informational only and does not constitute medical advice. Always consult your oncologist

Skip to content The CRC Digest ● US senators demand explanation for halted cancer screening task force Nineteen US senators called on HHS Secretary Kennedy to explain why the US Preventive Services Task Force—which determines which cancer screenings Americans can access at no cost—has not met for a year

Skip to content The CRC Digest ▪ Fecal hemoglobin testing improves survival in symptomatic patients Retrospective study shows that using fecal hemoglobin levels to prioritize which symptomatic patients get colonoscopy first was associated with improved colorectal cancer-specific survival, suggesting this approach helps identify high-risk patients more quickly. (British Journal of Cancer)

Skip to content The CRC Digest Fecal hemoglobin levels may help triage patients for colon capsule endoscopy Researchers found that stratifying patients by fecal hemoglobin concentration could reduce re-investigation rates after colon capsule endoscopy, offering a potential alternative to colonoscopy in screening populations. (Therapeutic Advances in Gastroenterology) This content is

Skip to content The CRC Digest Fastest increases in CRC occur below age 45, especially rectal cancer While screening at age 45 may help, the steepest rise in early-onset cases is among those under 45, where population-wide screening is not cost-effective. (Cancer Epidemiology, Biomarkers & Prevention) This content is informational

Skip to content The CRC Digest Early-onset CRC rising in Switzerland despite overall decline A nationwide study from 1980–2021 shows colorectal cancer incidence declining in older adults but increasing in those under 50, mirroring global trends. (European Journal of Cancer) This content is informational only and does not constitute

Skip to content The CRC Digest ▸ ETV7 protein drives 5-FU resistance through immune pathway activation Elevated ETV7 expression in CRC promotes resistance to 5-fluorouracil chemotherapy by upregulating CXCL1, which triggers neutrophil extracellular trap formation and enhances tumor cell survival and invasion. (Communications Biology) This content is informational only and does